Lotus Resources Reports Uranium Production Delays at Kayelekera Due to Acid Plant Damage, Defers 2026 Deliveries

Acid Plant Damage Causes Production Delays at Kayelekera

Lotus Resources confirmed damage to the acid plant at its Kayelekera uranium project occurred during hot commissioning. This damage and required repairs are material information likely to affect the company's securities value. As the project’s core asset and main uranium revenue source, disruptions to the acid plant and commissioning progress represent a significant commercial impact for Lotus and its stakeholders.

The acid plant is vital for processing mined ore into uranium concentrate suitable for delivery. Damage sustained during commissioning necessitated repairs, directly causing production delays that prevent meeting contractual offtake obligations scheduled for the second half of 2026. The timing during hot commissioning—transitioning from construction to operational production—adds complexity to remediation and operational planning as the company balances repairs with production targets and customer commitments.

Offtake Delivery Deferrals and Ongoing Customer Negotiations

Lotus Resources has deferred 0.11 million pounds of U3O8 deliveries against its 2H 2026 contracted offtake. The company now forecasts delivering 0.20 million pounds in the second half of 2026, with 0.70 million pounds under active negotiation with customers. This adjustment materially affects near-term revenue and cash flow expectations, as the original commitment was for approximately one million pounds of uranium concentrate in 2026, predominantly in 2H, as disclosed in December 2025 and March 2026 quarterly reports.

Successful negotiation of delivery deferrals or rescheduling is critical to managing cash flow and operational credibility. While customer names and contract specifics remain undisclosed, ongoing negotiations for 0.70 million pounds indicate commercial flexibility, though outcomes remain uncertain. Pricing frameworks for these offtake agreements were previously disclosed on 3 September 2024, 29 January 2025, 17 March 2025, and 7 April 2026, enabling investors to evaluate mark-to-market impacts relative to uranium spot prices.

Production Inventory and Product Quality Challenges

As of this update, Lotus reported 124,000 pounds of U3O8 from Kayelekera pending final assay and classification to confirm specification compliance, alongside 93,000 pounds classified as off-specification. The company is considering options for off-spec material, including blending to meet specifications or selling at discounted prices. This inventory reflects typical commissioning-phase technical challenges and the acid plant damage’s impact on processing quality and yields.

Classification into on-specification, pending-assay, and off-specification categories is standard during ramp-up. Product acceptance at Orano CE’s conversion facility depends on independent laboratory testing, explaining the pending assay status. Assaying involves export permits, laboratory analysis, and review, extending final classification and revenue recognition over several months. Off-spec material can still generate revenue via alternative marketing channels, albeit at lower prices or after blending.

Need for Strategic External Funding to Maintain Operations

Lotus Resources disclosed a requirement for external strategic funding to sustain financial viability and ongoing Kayelekera operations. This need arises from commissioning delays, extended ramp-up, product quality issues, offtake deferrals, and capital costs for acid plant repairs and process optimisation. The company remains suspended from ASX trading and will not lift this suspension until finalising a critical strategic funding package.

The timing and terms of this funding represent a key near-term risk and milestone. Without it, the company faces constraints in funding repairs, covering operating expenses during extended ramp-up, meeting overheads, and servicing debt. This disclosure marks a significant development in Lotus’s financial and operational outlook, emphasizing the importance of securing funding that balances shareholder interests with necessary capital.

Process Optimisation Program to Achieve Steady-State Production

Lotus has launched a Process Optimisation Program to transition Kayelekera from restart and commissioning to steady-state production. This includes capital upgrades and operational improvements outlined in the ASX Aware Letter dated 11 May 2026. This program is separate from acid plant repairs and aims to stabilise operations, enhance product quality, and meet production and recovery targets in the Accelerated Restart Plan and Ore Reserve estimates.

The transition requires coordinated capital investment, staffing, process adjustments, and quality controls. The company has not provided specific ramp-up metrics but maintains no material changes to steady-state assumptions despite delays. However, the acid plant damage likely extends the timeline to reach steady-state production.

Metallurgical Accounting Review and Production Data Reconciliation

Lotus is finalising a Novamet metallurgical accounting and reconciliation review to reassess processing data including recovery rates and ore milled through December 2025. The key production metric is "Uranium Produced," representing final assayed and classified uranium concentrate. This figure has been reported in quarterly updates, including December 2025, March 2026, and monthly updates in June and July 2026.

Distinguishing interim metallurgical parameters from final Uranium Produced output is vital for assessing production reliability. Recovery rates and ore milled vary during ramp-up but do not necessarily indicate steady-state capability changes. The Novamet review ensures consistency and accuracy as operations shift from commissioning to steady-state.

Kayelekera Project Overview and Operational Environment

The Kayelekera uranium project in Malawi is Lotus Resources’ primary asset and revenue source. Currently in restart and commissioning, the project was developed for uranium mining and processing and is being reactivated under an Accelerated Restart Plan. It includes mining, processing infrastructure such as the acid plant, and offtake agreements with established nuclear fuel cycle participants including Orano CE.

Located in Malawi, a Southern African country experienced in uranium mining, the project benefits from skilled labor, mining infrastructure, and regulatory frameworks. However, its remote location and complex supply chains contribute to commissioning challenges, especially for specialized equipment and assay facilities. Operations are subject to Malawian regulatory, environmental, and safety requirements, as well as international offtake agreements.

Offtake Agreements and Customer Relations

Lotus holds uranium concentrate offtake agreements with customers including Orano CE. The 2026 commitments total about one million pounds of U3O8, with 90-100% scheduled for delivery in 2H 2026, as reported in quarterly disclosures. Pricing details have been provided in prior announcements dated 3 September 2024, 29 January 2025, 17 March 2025, and 7 April 2026, with further commitment details in the 2025 Annual Financial Report.

These agreements provide revenue visibility and financing certainty if production targets are met. However, current delays and deferrals expose the company to financial and reputational risks. While a theoretical maximum liability of approximately US$10 million exists if no deliveries occur and no deferrals are agreed, this is not considered material. The ongoing negotiations indicate active management of delivery timelines rather than defaults.

ASX Trading Suspension and Conditions for Reinstatement

Lotus Resources remains suspended from ASX trading and has informed ASX Compliance it will not lift the suspension until a strategic funding package critical to financial viability is secured. The suspension was imposed to ensure material information about production delays, acid plant damage, and funding needs was fully disclosed before market trading resumed. The company views funding finalisation as a prerequisite for reinstatement and operational guidance.

Reinstatement will likely require announcement of funding terms, updated production and delivery guidance reflecting current ramp-up status, and ASX Compliance approval confirming full disclosure and reliable market guidance. The suspension duration depends on funding negotiations and completion of related due diligence and documentation. Investors should note no trading is possible during suspension, with reinstatement timing uncertain.

Investor Implications and Market Context

Investors face significant uncertainty regarding Lotus Resources’ near-term operations, funding, and shareholder value. Acid plant damage and production delays reduce 2026 revenue prospects and pressure cash flow during ramp-up. The need for external funding introduces risks of dilution and capital structure changes. Offtake deferral negotiations provide some flexibility but do not resolve core challenges.

Global uranium demand remains strong due to nuclear power growth and energy security concerns, but spot prices fluctuate. The company’s ability to monetise offtake commitments and inventory depends on market conditions at delivery. Prior pricing disclosures enable mark-to-market assessment, but future spot prices and terms for off-spec or deferred production sales remain uncertain. Lotus’s transparent disclosure to ASX is a positive step, but investors should consult qualified financial advisers before making investment decisions.